Sort   by:  
 Page size 
UnknownTherapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
Not available
S-EPMC8653024 | biostudies-literature
UnknownRisk of COVID 19 in patients with inflammatory bowel diseases compared to a control population.
Not available
S-EPMC7762705 | biostudies-literature
UnknownSARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.
Not available
S-EPMC10324268 | biostudies-literature
UnknownBowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study.
Not available
S-EPMC11834362 | biostudies-literature
UnknownClinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
Not available
S-EPMC7668225 | biostudies-literature
UnknownDiverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis.
Not available
S-EPMC10493361 | biostudies-literature
UnknownOutcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
Not available
S-EPMC9162476 | biostudies-literature
UnknownCOVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
Not available
S-EPMC9047221 | biostudies-literature
Sort   by:  
 Page size